Virax Biolabs Group Ltd 20-F for FY2024
Virax Biolabs Group Ltd (VRAX)
20-F
2024-08-20
For: 2024-03-31
View Original
Added on
April 08, 2026
About this 20-F
Virax Biolabs Group Ltd filed this 20-F on August 20, 2024, covering the fiscal year ended March 31, 2024 (FY2024).
Headline figures
Fiscal year ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $156.42K
- up 1727.1% from $8561 a year earlier
- Net loss
- $6.73M
- compared with a net loss of $5.46M a year earlier
- Diluted EPS
- -$3.36
- compared with -$5.13 a year earlier